Introduction
Since the original description of Ca 2ϩ entry triggered by depletion of intracellular Ca 2ϩ stores (Putney, 1986) , progress has been slow to identify the plasma-membrane channels involved in this phenomenon. Transient receptor potential channels (TRPCs), a family of relatively nonselective divalent cation channels, have been proposed as the molecular entity associated with store-operated Ca 2ϩ channel activity (Zhu et al., 1996) . Several reports have shown functional similarities between storeoperated Ca 2ϩ channels and TRPCs, especially the type-3 TRPC (TRPC3) (Zhu et al., 1996; Vazquez et al., 2001; Montell et al., 2002) . Both store-operated Ca 2ϩ channels and TRPCs may be operated through a physical link with the inositol trisphosphate (InsP 3 ) receptor and/or by InsP 3 itself (Ma et al., 2000; Vazquez et al., 2001) . Several alternative or complementary TRPC operation models are still under investigation . However, recent studies also point out substantial differences between the properties of store-operated Ca 2ϩ channels and TRPCs (Montell et al., 2002) .
Little is known about capacitative Ca 2ϩ entry, store-operated Ca 2ϩ channels, or TRPC function in the Ca 2ϩ homeostasis of type I astrocytes. In this study, we analyzed the properties and the behavior of capacitative Ca 2ϩ entry in type I astrocytes and C6 glioma cells, with the aim of clarifying the role of natively expressed TRPCs in this phenomenon. We were able to pharmacologically distinguish store-operated Ca 2ϩ channel function from TRPC activity. Furthermore, we identified a possible role for oleyl-acetyl-glycerol (OAG)-sensitive TRPC activation in the generation of a novel form of astrocytic [Ca 2ϩ ] i oscillations.
Materials and Methods
Cell cultures. Type I astrocyte cultures were obtained from embryonic day 17 rats according to a published protocol (Grimaldi et al., 1994) . Briefly, fetuses were obtained by cesarean section from a 17 d pregnant Wistar rat and quickly decapitated. The heads were placed in PBS (Invitrogen, Gaithersburg, MD) containing 4.5 gm/l glucose at room temperature. Cerebral cortices were dissected, minced, and enzymatically digested with papain. The tissue fragments were then mechanically dissociated. The cells in suspension were counted and plated in 25cm 2 flasks (106 cells per flask). The culture medium (DMEM, high glucose) was changed after 6 -8 hr to wash away unattached cells. Subsequently, the medium was changed every 2 d. This yielded cultures consisting of Ͼ95% type I astrocytes as characterized by glial fibrillary acidic protein immunoreactivity (Grimaldi et al., 1999) . C6 glioma cells were purchased from American Type Culture Collection (ATCC, Manassas, VA), amplified, and frozen in liquid nitrogen. Thawed cells retained functional characteristics for up to 25 passages, and then they were discarded. C6 glioma cells were maintained in high-glucose DMEM containing 10% fetal bovine serum (HyClone, Logan, UT) and penicillin-streptomycin. Subcultures were obtained by trypsin-EDTA exposure.
Single cell [Ca 2ϩ ] i measurements. Nearly confluent type I astrocytes and C6 glioma cells were seeded onto 1.5-cm-diameter glass coverslips (Assistent, Sondheim/Rhön, Germany). Before the experiment, cells were washed once in Krebs'-Ringer's buffer (KRB) containing the following (in mM): 125 NaCl, 5 KCl, 1 Na 2 HPO 4 , 1 MgSO 4 , 1 CaCl2 1, 5.5 glucose, and 20 HEPES, pH 7.3. They were then loaded with 4 M fura-2 AM (Molecular Probes, Eugene, OR) for 22 min at room temperature under continuous gentle agitation. After loading, cells were washed once with fresh KRB and then incubated for an additional 22 min in KRB without fura-2 AM, according to a previously published protocol (Grimaldi et al., 1999) . Finally, the coverslips were mounted on a lowvolume, self-built 150 l perfusion chamber and placed on an inverted microscope equipped with a 40ϫ lens and a CCD video camera. Preparations were perfused with KRB through a peristaltic pump at ϳ800 l/min. Ca 2ϩ -free solutions were prepared by omitting Ca 2ϩ from the KRB and including 100 M EGTA. Ratio measurements were performed every 2 sec by collecting image pairs exciting the preparations at 340 and 380 nm, respectively. The excitation wavelengths were changed through a high-speed mechanical filter changer, and the emission wavelength was set at 510 nm. The captured images were digitized using an acquisition board and analyzed by using commercially available software. Ratio values were derived from the entire cytosolic area, obtained by delimiting the profile of the cells and averaging the signal within the delimited area, and were converted into [Ca 2ϩ ] i using the equation described by Grynkiewicz et al. (1985) . F max in astrocytes and in C6 was obtained exposing cells to 10 M ionomycin in 10 mM extracellular Ca 2ϩ . F min was obtained with a Ca 2ϩ -free solution containing 1 mM EDTA. Reverse transcription-PCR. Primers to the six isoforms of TRPC1-TRPC6 and to ␤-actin were designed according to published sequences (Pizzo et al., 2001) . RNA was extracted from type I astrocytes and C6 using the RNAeasy Qiagen Mini Kit (Qiagen, Valencia, CA) and quantified by spectrometry. Total RNA (1 g) was added to the reaction mixture containing two sets of primers, one for the specific TRPC and the other for ␤-actin. Reverse transcription (RT)-PCR amplifications were performed using the Superscript One-Step RT-PCR with Platinum Taq Kit (Qiagen). Forty amplification cycles were conducted with denaturation at 94°C for 2 min, annealing at 57°C for 30 sec, and extension at 70°C for 1 min. Results were expressed as ratio of TRPC product to ␤-actin.
Antisense oligonucleotides were designed on the basis of the sequence specificity. We synthesized an antisense on the basis of the primers used for the PCR, specific for the isoform TRPC3. We also synthesized fluoresceinate antisense, sense, and scrambled oligonucleotides. Astrocytes were treated with 100 g/ml antisense, sense, or scrambled oligonucleotides and with fluoresceinate antisense to control for uptake. After ϳ2 hr of treatment, fluorescence was discretely accumulated within astrocytes in hot spots. Cells were treated with the oligonucleotides in the presence of serum for 36 hr, and loaded with fura-2, and then exposed to OAG.
Western blot. Proteins were extracted from type I astrocytes and C6 glioma cells using the Protease Arrest kit (Geno Technology, St. Louis, MO). Protein content of the samples was quantified using the Bradford assay (Bradford, 1976) . Protein samples (100 g) were prepared for SDS-PAGE using the PAGE perfect kit (Geno Technology), mixed with 2ϫ Laemmli buffer containing 100 mM dithiotretiol, and then heated at 70°C for 30 min. Protein extract (100 g) were loaded in each lane of a 12-4% gradient gel and separated. Electrophoresed proteins were transferred and immobilized on a nitrocellulose membrane. Membranes were exposed to 5% nonfat dry milk to block unspecific binding sites. Immunoblots with anti-TRPC3 or TRP4 antibodies (Alomone Labs, Jerusalem, Israel) were conducted using a 1:200 dilution overnight, according to the instructions of the manufacturer, at room temperature. After washing the membranes, bound primary antibody was detected by exposing the filter to ImmunoPure goat anti-rabbit IgG (Pierce, Rockford, IL) at a 1:2500 dilution for 6 hr at room temperature. The SuperSignal Enhanced Chemiluminescence kit (Pierce) was used to visualize immunoreactive bands.
Immunocytochemistry and confocal analysis of TRPC3 and TRPC4 localization. Type I astrocytes and C6 cells seeded on coverslips were fixed in 4% paraformaldehyde in PBS. Cells were incubated with primary antibody to TRPC3 and TRPC4, at 1:25 dilution, for 4 hr at room temperature (Alomone Labs). Preparations were washed several times in PBS.
Secondary FITC-conjugated antibody at 1:200 dilution was incubated for 1 hr at room temperature. Preparations were washed several times in PBS. Coverslips were mounted using Immunomount containing the antifade agent DABCO (1,4-diazabicyclo-[2.2.2]octane). Preparations were observed with an inverted microscope using 40ϫ oil immersion high numerical aperture Olympus Optical (Tokyo, Japan) lens. Images were enlarged using the optical zoom of the microscope; therefore, final magnification was 60ϫ. Images were digitized using commercially available software.
Materials. All materials were purchased from Sigma (St. Louis, MO), unless otherwise specified in the text.
Use 
Results

Store-operated Ca
2؉ channels in type I astrocytes and in C6 cells do not exhibit TRPC properties We depleted intracellular Ca 2ϩ stores by exposure to 2 M thapsigargin, an irreversible inhibitor of the sarcoendoplasmic reticulum Ca 2ϩ ATPase (SERCA) (Thastrup et al., 1989) , in the absence of extracellular Ca 2ϩ . After an initial rise, [Ca 2ϩ ] i requilibrated to baseline levels. When extracellular Ca 2ϩ was reintroduced to initiate capacitative Ca 2ϩ entry, a rapid and sustained elevation of [Ca 2ϩ ] i was detected in both astrocytes and C6 cells (Fig. 1 A, D) .
Store-operated Ca 2ϩ channels are highly selective (Hoth and Penner, 1992; Parekh and Penner, 1997) , whereas TRPCs are less selective and also permeable to the larger Sr 2ϩ and Ba 2ϩ cations (Hoth and Penner, 1992; Estacion et al., 1999) . Like Ca 2ϩ , both Sr 2ϩ and Ba 2ϩ increase the ratio signal of fura-2 by, during binding to the probe, decreasing fluorescence emission at 510 nm when excitation is set at 380 nm and increasing the fluorescence emission at 510 nm when excitation is set at 340 nm (Kwan and Putney, 1990 We also depleted intracellular Ca 2ϩ stores with ATP, a purinergic P2 y receptor agonist that induces the production of the second messengers InsP 3 and DAG (Shao and McCarthy, 1993 ).
We exposed astrocytes and C6 cells to ATP [10 M for astrocytes (Grimaldi et al., 1999) and 100 M for C6 cells] because these two cell types have different sensitivity to ATP (Sabala et al., 2001) in the absence of extracellular Ca 2ϩ . Cells were continuously perfused with ATP until [Ca 2ϩ ] i reequilibrated to baseline levels, at which time ATP was washed out. We demonstrated previously that such a treatment causes the complete depletion of intracellular Ca 2ϩ stores (Grimaldi et al., 2001) . As during thapsigargin treatment, Sr 2ϩ ( Fig. 2 ) and Ba 2ϩ (data not shown) did not enter both astrocytes and C6 cells, again suggesting that capacitative Ca 2ϩ entry is not achieved via the opening of a channel with TRP-like ion conductance selectivity.
Astrocytes and C6 glioma cells differentially express TRPCs
Using RT-PCR, we showed that astrocytes express mRNA for all six TRPC subtypes ( Fig. 3A) (Pizzo et al., 2001 ). C6 cells do not express TRPC4 and express very little if any TRPC6 (Fig. 3 , B vs A). Lack of TRPC4 in C6 cells was confirmed by Western blot ( Fig. 3C-E ) and immunocytochemistry. TRPC3 is the most abundant isoform to be expressed in the two cell types, as shown by densitometric analysis of the TRPCs versus ␤-actin amplification products in the same RT-PCR reactions (Fig. 3 A, B , bar graphs) and by Western blot (Fig. 3G ).
OAG activation of TRPCs induces high-amplitude, low-frequency [Ca 2؉ ] i oscillations
Several studies have reported that OAG causes the opening of TRPC3 and TRPC6 and in some instances of TRPC1, independent of lipid-sensitive protein kinase C activation (Hofmann et al., 1999) . OAG gates a nonselective cationic channel permeable to Ca 2ϩ , Sr 2ϩ , and Ba 2ϩ (Estacion et al., 1999) . To determine whether OAG-activated TRPCs play a role in Ca 2ϩ homeostasis in glial cells, we exposed astrocytes and C6 cells to OAG (100 M) and monitored [Ca 2ϩ ] i . After a short latency, OAG induced large, low-frequency [Ca 2ϩ ] i oscillations in both astrocytes (Fig.  4 A) and C6 cells (Fig. 4 E) . Individual [Ca 2ϩ ] i oscillations reached very high [Ca 2ϩ ] i values and decreased almost to baseline over a period of several seconds. [Ca 2ϩ ] i oscillations were observed throughout a 10 min period of exposure to OAG (data not shown). During wash out, cells ceased oscillatory activity, demonstrating that the action of OAG was readily reversible. Approximately 90% of the astrocytes (n ϭ 798) (Fig. 4 D) and 45% of the C6 cells studied (n ϭ 954) (Fig. 4 H (Shuttleworth, 1996; Estacion et al., 1999; Hofmann et al., 1999; Lintschinger et al., 2000; Ma et al., 2000; Vazquez et al., 2001; Montell et al., 2002; Trebak et al., 2002) .
OAG-induced [Ca 2ϩ ] i oscillations were maintained in extracellular solution containing 1 mM Sr 2ϩ and no Ca 2ϩ , indicating that they were, attributable to the opening of a nonselective cation channel, likely a TRPC (Fig. 4 B, F Treatment of astrocytes with an antisense (100 g/ml) designed to inhibit the expression of TRPC3 greatly reduced the percentage of astrocytes responding to OAG (Fig. 5) . Approximately 99% of the astrocytes treated with vehicle (n ϭ 154; r ϭ 3) or sense sequence (n ϭ 130; r ϭ 3) responded to OAG exposure with [Ca 2ϩ ] i oscillations as untreated cells. Only ϳ35% of the antisense-treated astrocytes (n ϭ 212; r ϭ 4) responded to OAG (a 75% inhibition) versus both vehicle or sensetreated cells.
Regulation of OAG-induced [Ca 2؉ ] i oscillations
We studied OAG-triggered [Ca 2ϩ ] i oscillations under conditions affecting InsP 3 production.
Pretreatment with phorbol esters has been shown to inhibit both phospholipase C (PLC) activity (Chuprun and Rapoport, 1997) and InsP 3 -sustained [Ca 2ϩ ] i oscillations (Chuprun and Rapoport, 1997 (Ribeiro and Putney, 1996) . We treated astrocytes with phorbol 12-myristate 13-acetate (PMA) and then stimulated the cells with the purinergic agonist ATP (10 M). PMA pretreatment strongly reduced the ATP-triggered elevation of [Ca 2ϩ ] i (Fig. 6, compare A,  B) . However, PMA pretreatment did not affect OAG-induced [Ca 2ϩ ] i oscillations (Fig. 6 D) . 2-Amino phenyl borane (2-APB), a cell-permeable antagonist of InsP 3 (Maruyama et al., 1997) , also strongly reduced the ATP response (Fig. 6C) without affecting OAG-induced [Ca 2ϩ ] i oscillations (Fig. 6 E) . Finally, preexposure to a lower concentration of OAG before challenging the cells with a fully effective concentration of OAG did not abolish or reduce OAG-induced [Ca 2ϩ ] i oscillations (Fig. 6 F) . We next asked whether [Ca 2ϩ ] i could regulate the activity of the OAG-sensitive TRPC. We used different experimental approaches to elevate [Ca 2ϩ ] i to different levels and assessed the function of OAG-activated TRPC. ATP exposure was not able to trigger [Ca 2ϩ ] i oscillations (Fig. 7A) , nor did it affect OAGinduced [Ca 2ϩ ] i oscillations (Fig. 7B) . However, OAG-induced [Ca 2ϩ ] i oscillations in the presence of ATP were completely prevented by extracellular Ca 2ϩ withdrawal, whereas ATP response was completely preserved (Fig. 7B, inset) . The [Ca 2ϩ ] i transient evoked by ATP is characterized by a rapid peak, followed by a prolonged plateau phase at a lower [Ca 2ϩ ] i . The latter could not be high enough to affect TRPCs. Therefore, we evaluated the effect of a more prolonged and marked [Ca 2ϩ ] i elevation. Thapsigargin causes a prolonged elevation of [Ca 2ϩ ] i and avoids reuptake in the intracellular Ca 2ϩ stores (Fig. 8 A) . In the presence of thapsigargin and extracellular Ca 2ϩ , OAG-triggered [Ca 2ϩ ] i oscillations were still observed. The increasingly higher [Ca 2ϩ ] i reached after each oscillation was attributable to the inability of the thapsigargin-treated cells to take up Ca 2ϩ in the intracellular Ca 2ϩ stores (Fig. 8 B) . OAG-induced [Ca 2ϩ ] i oscillations in the presence of thapsigargin were preserved in the presence of extracellular Sr 2ϩ , indicating that TRPC can still be activated in this condition (Fig. 8 D) . Additionally, this set of experiments indicates that TRPC opening is not potentiated by intracellular Ca 2ϩ stores depletion, contrary to what one would expect, if TRPC was being operated by intracellular Ca 2ϩ stores depletion (Fig. 8 B) . Whereas ATP and thapsigargin individually do not affect OAG-induced [Ca 2ϩ ] i oscillations, the simultaneous exposure to ATP and thapsigargin caused a high, long-lasting [Ca 2ϩ ] i elevation (Fig. 9A) and completely prevented OAG-induced oscilla- Figure 3 . Expression of TRPC in astrocytes and C6 glioma cells. A, mRNA extracted from astrocytes was amplified with primers designed to amplify TRPC1-TRPC6 and ␤-actin (as an internal control to normalize amplification conditions and mRNA loading). The arrows flanking the gels highlight amplification product size (TRPC1, 345 bp; TRPC2, 193 bp; TRPC3, 457 bp; TRPC4, 417 bp; TRPC5, 131 bp; TRPC6, 116 bp). B, mRNA extracted from C6 was amplified with primers designed to amplify TRPC1-TRPC6 and ␤-actin. C, Ratio of TRPC1-TRPC6 versus ␤-actin in type I astrocytes was calculated, and results were plotted in bar graphs. TRPC3 resulted to be the most abundant isoforms; TRPC4 and TRPC2 were also abundant. D, Ratio of TRPC1-TRPC6 versus ␤-actin in C6 cells. TRPC3 was the most abundant isoform. TRPC4 yielded no amplification product, and TRPC6 was almost undetectable. E, Localization of TRPC3 in rat astrocytes obtained via indirect immunofluorescence detection. Scale bar, 10 m. F, Localization of TRPC3 in C6 cells obtained via immunofluorescence detection. Scale bar, 10 m distance. G, Western blot of TRPC3 in astrocytes and C6 cells. Proteins extracted from astrocytes and C6 cells were immunoblotted with anti TRPC3 antibody, and an immunoreactive band was detected at the expected molecular weight of ϳ115 kDa in both cell types. H, Localization of TRPC4 in rat astrocytes obtained via immunofluorescence detection. Scale bar, 10 m. I, Western blot with anti-TRPC4 antibody in type I astrocytes and C6 cells. An immunoreactive band was detected at the expected molecular weight of ϳ97 kDa in astrocytes but not in C6 cells.
tions. This suggests that a large [Ca 2ϩ ] i elevation may block OAG-sensitive TRPC function (Fig. 9A vs B) . To assess whether, in the presence of ATP, thapsigargin, and OAG, the OAGsensitive TRPCs are open and only the oscillatory activity is lost, we exposed the cells to ATP-thapsigarin-OAG in the presence of extracellular Sr 2ϩ . Stimulation of astrocytes with ATP and thapsigargin did not result in any Sr 2ϩ entry (Fig. 9C) . When astrocytes were exposed to ATP-thapsigargin-OAG, again no Sr 2ϩ influx was recorded, suggesting that, after a large [Ca 2ϩ ] i elevation, as achieved with the simultaneous exposure to ATP and thapsigargin, the OAG-sensitive TRPC is closed (Fig. 9C vs D) . We performed an additional experiment using Ba 2ϩ , which is also conducted by OAG-sensitive TRPCs, but is not pumped into the endoplasmic reticulum by SERCA (Vanderkooi and Martonosi, 1971; Kwan and Putney, 1990 ). Ba 2ϩ is also not able to interact with most of the Ca 2ϩ -binding proteins (Eckert and Tillotson, 1981; Hagiwara and Ohmori, 1982) . However, Ba 2ϩ still binds to fura-2 and causes an increase of 340:380 ratio, similar to Ca 2ϩ (Kwan and Putney, 1990) . In the presence of extracellular Ba 2ϩ , OAG caused a progressive elevation of fura-2 ratio, indicating that, in the absence of [Ca 2ϩ ] i elevation, TRPCs are constantly opened by OAG (Fig. 10 ).
[Ca 2؉ ] i oscillations are not mimicked by endogenous DAG elevation
We conducted experiments designed to test whether endogenous DAG can trigger [Ca 2ϩ ] i oscillations similar to exogenously applied OAG. In other cells in which TRPCs were overexpressed, inhibition of DAG-lipase by RHC80276 activates TRPC channels, presumably via the accumulation of basally released and uncatabolized DAG (Hofmann et al., 1999; Ma et al., 2000) . In ] i oscillations. Astrocytes were treated for 36 hr with vehicle, and 100 g/ml TRPC3 sense or antisense oligonucleotides were loaded with fura-2 and then exposed to 100 M OAG. Open bars indicate responding cells, and filled bars indicate nonresponding cells. Anti-TRPC3 oligunucleotide treatment significantly reduced the number of astrocytes (AS) responding to OAG. Statistical analysis was performed with Wilcoxon ranked test. * indicates a significant difference versus vehicle.
astrocytes, RHC80276 alone did not evoke an elevation of [Ca 2ϩ ] i (Fig. 11 A) . Because it was conceivable that basal release of DAG in astrocytes may be very low, we analyzed the effect of RHC80276 in conjunction with a PLC-stimulating agonist, with the aim of causing a greater elevation of DAG concentration and unveiling DAG-activated [Ca 2ϩ ] i oscillations. Exposure to ATP, which did not affect OAG-induced [Ca 2ϩ ] i oscillations (Fig. 7A) , in the presence of RHC80276, did not trigger [Ca 2ϩ ] i oscillations (Fig. 11 B) (Grimaldi et al., 1999 (Grimaldi et al., , 2001 Jung et al., 2000) . The duration and the magnitude of [Ca 2ϩ ] i transients are important determinants of the intracellular cascades activated by extracellular signals. Therefore, characterization of capacitative Ca 2ϩ entry regulation is necessary to tease apart multiple signaling pathways. The channels responsible for capacitative Ca 2ϩ entry have not yet been identified, but evidence supports an overlap of functions between storeoperated Ca 2ϩ channels activity and the TRPC family of ion channels (Zhu et al., 1996; Vazquez et al., 2001; Montell et al., 2002) . However, several differences have been reported between store-operated Ca 2ϩ channels and TRPC function (Montell et al., 2002) . Moreover, most studies that implicate TRPC isoforms in store-operated Ca 2ϩ channels function do so in heterologous systems in which the TRPC isoforms are overexpressed (Hofmann et al., 1999; Ma et al., 2000; Vazquez et al., 2001; Trebak et al., 2002) . We studied capacitative Ca 2ϩ entry in the native environment of type I astrocytes and C6 glioma cells with the aim of characterizing store-operated Ca 2ϩ channels activity and TRPCs function, their involvement in capacitative Ca 2ϩ entry, and their contribution to intracellular Ca 2ϩ homeostasis. We were able to demonstrate that store-operated Ca 2ϩ channels and TRPC activity are functionally distinct entities. In fact, capacitative Ca 2ϩ entry triggered by intracellular Ca 2ϩ stores depletion via both agonist or SERCA inhibitor exposure resulted in extracellular Ca 2ϩ influx (capacitative Ca 2ϩ entry) via a channel activity that is extremely selective in its ion permeability, like typical storeoperated Ca 2ϩ channels. During capacitative Ca 2ϩ entry, Ca 2ϩ is allowed entry into astrocytes and C6 cells, but the larger cations Sr 2ϩ and Ba 2ϩ are not (Hoth and Penner, 1992; Parekh and Penner, 1997 glial cells. To study the effect of TRPC opening in glial cells, we used the DAG analog OAG, which specifically activates certain subtypes of TRPC implicated in capacitative Ca 2ϩ entry in other systems (Ma et al., 2000; Vazquez et al., 2001) , in a protein kinase C-unrelated manner (Hofmann et al., 1999) . (Hofmann et al., 1999; Lintschinger et al., 2000) . TRPC6 is also not expressed in C6 cells. TRPC4, which is expressed in type I astrocytes, but not in C6, has been implicated in muscarinic receptoractivated [Ca 2ϩ ] i oscillations (Wu et al., 2002) . However, TRPC4-induced [Ca 2ϩ ] i oscillations required agonist exposure to be triggered, a substantial difference from OAG-induced oscillations, which do not require agonist exposure. Additionally, our finding that TRPC4s are not expressed in C6, although C6 cells responded to OAG exposure with [Ca 2ϩ ] i oscillations, further strengthen the view that TRPC4 plays no part in [Ca 2ϩ ] i oscillations triggered by OAG. Pharmacological and molecular evidence seemed to strongly implicate activation of TRPC3 in the OAG-triggered [Ca 2ϩ ] i oscillations observed in astrocytes and C6 cells. To directly implicate TRPC3 in [Ca 2ϩ ] i oscillations evoked by OAG exposure, we conducted an additional set of experiments molecularly ablating the channel with antisense oligonucleotides. We designed a specific antisense oligonucleotide directed toward TRPC3 in an isoform-specific region on the basis of the PCR template. When primers with the same sequence are used in PCR, they amplify a single band corresponding to the number of base pairs anticipated on the basis of TRPC3 sequence (Fig. 3) . Treatment of astrocytes with this antisense inhibited the number of cells responding to OAG by 75%, strongly implicating this isoform of TRPC in the phenomenon we described in this study.
[ . Astrocytes were perfused with 1 mM Ba 2ϩ and 0 Ca 2ϩ . Cells were then exposed to 100 M OAG, which caused a gradual and large elevation of fura-2 ratio signal (R 340/380 ).
including astrocytes (Berridge, 1990; Charles et al., 1991; Fatatis and Russell, 1992; Pasti et al., 1995 Pasti et al., , 1997 Pasti et al., , 2001 Yagodin et al., 1995; Parri et al., 2001) . Oscillations are known to trigger several biological responses, including secretion and gene expression (Berridge, 1990; Dolmetsch et al., 1998) . Uncontrolled [Ca 2ϩ ] i oscillations have also been implicated in specific neuropathological conditions, such as specific forms of epilepsy (Manning and Sontheimer, 1997; Tashiro et al., 2002) . Classically, [Ca 2ϩ ] i oscillations in astrocytes are viewed as a phenomenon dependent on InsP 3 signaling and intracellular Ca 2ϩ release (Hajnoczky and Thomas, 1997) . The OAG-triggered [Ca 2ϩ ] i oscillations, which we report here for the first time and which we ascribe to TRPC3 activation, could also potentially involve InsP 3 and mobilization of intracellular Ca 2ϩ (Hajnoczky and Thomas, 1997) . However, blockade of InsP 3 signaling with 2-APB or by downregulation of PLC by pretreatment with phorbol esters (Ribeiro and Putney, 1996; Chuprun and Rapoport, 1997; Maruyama et al., 1997) (Eckert and Tillotson, 1981; Hagiwara and Ohmori, 1982) , causing the inhibition of the channel by high [Ca 2ϩ ] i to fail. It is commonly believed that the second messenger operating the TRPC3 channels is DAG (Hofmann et al., 1999) . The data we present here suggest that cytosolic DAG elevation is not able to trigger TRPC opening. Previous studies have demonstrated that, in cells overexpressing TRPC6 (Hofmann et al., 1999) and TRPC3 (Ma et al., 2000) , DAG elevation by means of the DAG lipase inhibitor RHC80276 caused an influx of extracellular cations, such as Mg 2ϩ and Ba 2ϩ (Hofmann et al., 1999; Ma et al., 2000) . In astrocytes and in C6 cells, we did not show such an effect of RHC80276 either in basal conditions or after the stimulation of the production of DAG by PLC activation by ATP. Therefore, we hypothesize that, in natively expressed TRPC3 in astrocytes, the OAG-sensitive site may be inaccessible to endogenously released DAG. This suggests the possibility that an extracellular substance, chemically related to OAG, may be the actual ligand responsible for the operation of OAG-sensitive TRPCs in physiological conditions.
In conclusion, we determined that store-operated Ca 2ϩ channels activity is not mediated by TRPC opening in glial cells. We also identified a potentially novel mode of Ca 2ϩ signaling in glial cells attributable to the activation of TRPC3. This novel mode of Ca 2ϩ signaling takes the form of high-amplitude [Ca 2ϩ ] i oscillations repeating at low frequency that is independent of InsP 3 and mobilization of intracellularly stored Ca 2ϩ , hence differing from previously described oscillatory phenomenon. These [Ca 2ϩ ] i oscillations are blocked by high [Ca 2ϩ ] i and may be induced by an extracellular congener of DAG, released by nearby neurons or astrocytes. We propose that such a signaling pathway may play a relevant role in glial physiology. 
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